These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Diagnostic value of HepPar1, pCEA, CD10, and CD34 expression in separating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration cytology. Saad RS; Luckasevic TM; Noga CM; Johnson DR; Silverman JF; Liu YL Diagn Cytopathol; 2004 Jan; 30(1):1-6. PubMed ID: 14696137 [TBL] [Abstract][Full Text] [Related]
4. Immunoperoxidase staining as a diagnostic aid for hepatocellular carcinoma. Christensen WN; Boitnott JK; Kuhajda FP Mod Pathol; 1989 Jan; 2(1):8-12. PubMed ID: 2466290 [TBL] [Abstract][Full Text] [Related]
5. Distinction between hepatocellular carcinoma, cholangiocarcinoma, and metastatic carcinoma based on immunohistochemical staining for carcinoembryonic antigen and for cytokeratin 19 on paraffin sections. Balaton AJ; Nehama-Sibony M; Gotheil C; Callard P; Baviera EE J Pathol; 1988 Dec; 156(4):305-10. PubMed ID: 2465399 [TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma versus carcinoma metastatic to the liver. Value of stains for carcinoembryonic antigen and naphthylamidase in fine needle aspiration biopsy material. Wong MA; Yazdi HM Acta Cytol; 1990; 34(2):192-6. PubMed ID: 2157322 [TBL] [Abstract][Full Text] [Related]
7. [Albumin mRNA and pCEA in the histopathologic diagnosis of hepatocellular carcinoma]. Foschini MP; Macchia S; Baccarini P; Milandri GL; Losi L; Spongano P; Panarelli M; Dal Monte PR; Eusebi V Pathologica; 1999 Aug; 91(4):260-7. PubMed ID: 10630075 [TBL] [Abstract][Full Text] [Related]
8. pCEA canalicular immunostaining in fine needle aspiration biopsy diagnosis of hepatocellular carcinoma. Wee A; Nilsson B Acta Cytol; 1997; 41(4):1147-55. PubMed ID: 9250313 [TBL] [Abstract][Full Text] [Related]
9. Conclusive diagnosis of hepatic and pancreatic malignancies by fine needle aspiration. Pilotti S; Rilke F; Claren R; Milella M; Lombardi L Acta Cytol; 1988; 32(1):27-38. PubMed ID: 2827417 [TBL] [Abstract][Full Text] [Related]
10. Two-color immunostaining of liver fine needle aspiration biopsies with CD34 and carcinoembryonic antigen. Potential utilization in the diagnosis of primary hepatocellular carcinoma vs. metastatic tumor. Yoder M; Zimmerman RL; Bibbo M Anal Quant Cytol Histol; 2004 Apr; 26(2):61-4. PubMed ID: 15131892 [TBL] [Abstract][Full Text] [Related]
11. Utility of polyclonal and monoclonal antibodies against carcinoembryonic antigen in hepatic fine-needle aspirates. Rishi M; Kovatich A; Ehya H Diagn Cytopathol; 1994 Dec; 11(4):358-61; discussion 361-2. PubMed ID: 7895575 [TBL] [Abstract][Full Text] [Related]
12. Immunocytochemical staining of fine-needle aspiration biopsies of the liver as a diagnostic tool for hepatocellular carcinoma. Johnson DE; Powers CN; Rupp G; Frable WJ Mod Pathol; 1992 Mar; 5(2):117-23. PubMed ID: 1374187 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver. Lin F; Abdallah H; Meschter S Diagn Cytopathol; 2004 Feb; 30(2):92-7. PubMed ID: 14755758 [TBL] [Abstract][Full Text] [Related]
14. Fine needle aspiration biopsy of hepatocellular carcinoma. Value of immunocytochemical and ultrastructural studies. Guindi M; Yazdi HM; Gilliatt MA Acta Cytol; 1994; 38(3):385-91. PubMed ID: 7514832 [TBL] [Abstract][Full Text] [Related]
15. Some cytologic features of hepatocellular carcinoma as seen in fine needle aspirates. Greene CA; Suen KC Acta Cytol; 1984; 28(6):713-8. PubMed ID: 6095567 [TBL] [Abstract][Full Text] [Related]
16. Discriminating hepatocellular carcinoma from metastatic carcinoma on fine-needle aspiration biopsy of the liver: the utility of immunocytochemical panel. Saleh HA; Aulicino M; Zaidi SY; Khan AZ; Masood S Diagn Cytopathol; 2009 Mar; 37(3):184-90. PubMed ID: 19170172 [TBL] [Abstract][Full Text] [Related]
17. Glypican-3 immunocytochemistry in liver fine-needle aspirates : a novel stain to assist in the differentiation of benign and malignant liver lesions. Kandil D; Leiman G; Allegretta M; Trotman W; Pantanowitz L; Goulart R; Evans M Cancer; 2007 Oct; 111(5):316-22. PubMed ID: 17763368 [TBL] [Abstract][Full Text] [Related]
18. A comparison of CD10 to pCEA, MOC-31, and hepatocyte for the distinction of malignant tumors in the liver. Morrison C; Marsh W; Frankel WL Mod Pathol; 2002 Dec; 15(12):1279-87. PubMed ID: 12481008 [TBL] [Abstract][Full Text] [Related]
19. Can CD34 discriminate between benign and malignant hepatocytic lesions in fine-needle aspirates and thin core biopsies? de Boer WB; Segal A; Frost FA; Sterrett GF Cancer; 2000 Oct; 90(5):273-8. PubMed ID: 11038423 [TBL] [Abstract][Full Text] [Related]
20. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma. Lau SK; Prakash S; Geller SA; Alsabeh R Hum Pathol; 2002 Dec; 33(12):1175-81. PubMed ID: 12514785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]